In a remarkable stride forward in the field of nanomedicine, Susana Carregal Romero, Ikerbasque Fellow, from our center will be spearheading the NanoSurf project, focused on developing lung surfactant-based nanomedicines aimed at targeted lung treatments.

"The delivery of targeted therapies is one of the current challenges in modern medicine that would greatly enhance the survival and quality of life of many patients," states Carregal Romero. The NanoSurf project, funded by the Ramón Areces Foundation, is poised to create new nanomaterials based on lung surfactant to improve the distribution, thereby increasing the efficiency of drugs targeted at treating lung diseases.

To achieve this, Carregal Romero, together with the Molecular and Functional Biomarkers team, will research the enhancement in pulmonary biodistribution of these new materials. They will assess their efficiency in improving treatments using idiopathic pulmonary fibrosis as an example, a potentially lethal disease partially associated with aging.

The potential implications of this project could be enormous, potentially revolutionizing the treatment methods for various pulmonary conditions. This pioneering work will not only contribute to the development of more effective targeted therapies but will also provide vital insight into the role of nanomedicines in the broader healthcare landscape.